271 related articles for article (PubMed ID: 37754852)
1. Lipid-Polymer Hybrid Nanosystems: A Rational Fusion for Advanced Therapeutic Delivery.
Jain S; Kumar M; Kumar P; Verma J; Rosenholm JM; Bansal KK; Vaidya A
J Funct Biomater; 2023 Aug; 14(9):. PubMed ID: 37754852
[TBL] [Abstract][Full Text] [Related]
2. Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics.
Gajbhiye KR; Salve R; Narwade M; Sheikh A; Kesharwani P; Gajbhiye V
Mol Cancer; 2023 Oct; 22(1):160. PubMed ID: 37784179
[TBL] [Abstract][Full Text] [Related]
3. Investigating the effectiveness of Difluprednate-Loaded core-shell lipid-polymeric hybrid nanoparticles for ocular delivery.
Kaviarasi B; Rajana N; Pooja YS; Rajalakshmi AN; Singh SB; Mehra NK
Int J Pharm; 2023 Jun; 640():123006. PubMed ID: 37137420
[TBL] [Abstract][Full Text] [Related]
4. Development and In Vitro Evaluation of Crizotinib-Loaded Lipid-Polymer Hybrid Nanoparticles Using Box-Behnken Design in Non-small Cell Lung Cancer.
Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Arica B
AAPS PharmSciTech; 2023 Sep; 24(7):178. PubMed ID: 37658977
[TBL] [Abstract][Full Text] [Related]
5. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives.
Mukherjee A; Waters AK; Kalyan P; Achrol AS; Kesari S; Yenugonda VM
Int J Nanomedicine; 2019; 14():1937-1952. PubMed ID: 30936695
[TBL] [Abstract][Full Text] [Related]
6. Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform.
Mandal B; Bhattacharjee H; Mittal N; Sah H; Balabathula P; Thoma LA; Wood GC
Nanomedicine; 2013 May; 9(4):474-91. PubMed ID: 23261500
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery.
Tahir N; Madni A; Li W; Correia A; Khan MM; Rahim MA; Santos HA
Int J Pharm; 2020 May; 581():119275. PubMed ID: 32229283
[TBL] [Abstract][Full Text] [Related]
8. Core Shell Lipid-Polymer Hybrid Nanoparticles for Oral Bioavailability Enhancement of Ibrutinib via Lymphatic Uptake.
Patel M; Desai A; Kansara V; Vyas B
AAPS PharmSciTech; 2023 Jun; 24(6):142. PubMed ID: 37353671
[TBL] [Abstract][Full Text] [Related]
9. EGF-functionalized lipid-polymer hybrid nanoparticles of 5-fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma.
Li S; Xu Z; Alrobaian M; Afzal O; Kazmi I; Almalki WH; Altamimi ASA; Al-Abbasi FA; Alharbi KS; Altowayan WM; Singh T; Akhter MH; Gupta M; Rahman M; Beg S
Biotechnol Appl Biochem; 2022 Oct; 69(5):2205-2221. PubMed ID: 34775646
[TBL] [Abstract][Full Text] [Related]
10. Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery - comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution.
Ishak RAH; Mostafa NM; Kamel AO
Drug Deliv; 2017 Nov; 24(1):1874-1890. PubMed ID: 29191047
[TBL] [Abstract][Full Text] [Related]
11. Development and
Yousaf R; Khan MI; Akhtar MF; Madni A; Sohail MF; Saleem A; Irshad K; Sharif A; Rana M
Heliyon; 2023 Mar; 9(3):e14281. PubMed ID: 36925532
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of pH-responsive dimethylglycine surface-modified branched lipids for targeted delivery of antibiotics.
Makhathini SS; Omolo CA; Kiruri LW; Walvekar P; Devnarain N; Mocktar C; Govender T
Chem Phys Lipids; 2022 Nov; 249():105241. PubMed ID: 36152880
[TBL] [Abstract][Full Text] [Related]
13. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
14. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications.
Tahir N; Madni A; Balasubramanian V; Rehman M; Correia A; Kashif PM; Mäkilä E; Salonen J; Santos HA
Int J Pharm; 2017 Nov; 533(1):156-168. PubMed ID: 28963013
[TBL] [Abstract][Full Text] [Related]
15. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
[TBL] [Abstract][Full Text] [Related]
16. Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy.
Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A
Life Sci; 2021 Nov; 284():119909. PubMed ID: 34450169
[TBL] [Abstract][Full Text] [Related]
17. Baicalin-Loaded Lipid-Polymer Hybrid Nanoparticles Inhibiting the Proliferation of Human Colon Cancer: Pharmacokinetics and In Vivo Evaluation.
Riadi Y; Afzal O; Geesi MH; Almalki WH; Singh T
Polymers (Basel); 2023 Jan; 15(3):. PubMed ID: 36771901
[TBL] [Abstract][Full Text] [Related]
18. Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery.
Bose RJC; Tharmalingam N; Choi Y; Madheswaran T; Paulmurugan R; McCarthy JR; Lee SH; Park H
Int J Nanomedicine; 2020; 15():8437-8449. PubMed ID: 33162754
[TBL] [Abstract][Full Text] [Related]
19. Harnessing Lipid Polymer Hybrid Nanoparticles for Enhanced Oral Bioavailability of Thymoquinone: In Vitro and In Vivo Assessments.
Imam SS; Gilani SJ; Bin Jumah MN; Rizwanullah M; Zafar A; Ahmed MM; Alshehri S
Polymers (Basel); 2022 Sep; 14(18):. PubMed ID: 36145851
[TBL] [Abstract][Full Text] [Related]
20. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
